Dual Targeting, Singular Precision
Our minimalist binders seamlessly integrate into multispecific constructs, expanding functional binding footprints and enhancing effective binding affinity through bivalency. With our rapid optimization processes, we can drive functional affinity into the low picomolar regime within weeks, accelerating the development of high-affinity, precision-targeted therapeutics faster than ever before.
This plug-and-play modularity also enables the rapid development of bimolecular bispecifics, allowing the straightforward, combinatorial production of matchmaker molecules facilitating novel biology.
With efficient workflows for multispecific development, we’re opening new frontiers in targeted therapy – unlocking dual targeting with singular precision.
Our platform enables the direct identification of high-affinity binders with tailored functional effects (whether neutralizing, modulating, or binding without interference), offering a new degree of control in therapeutic design.
This tunable functionality enables the rapid development of bespoke therapeutics, optimized for diverse mechanisms of action, from robust receptor silencing to precision pathway modulation.
This isn’t discovery by chance – it’s function by design.